Latest GM & Biosafety Resources

Oxitec’s failed GM mosquito releases worldwide: Forewarnings for Africa and the Target Malaria project

A decade ago, genetically modified (GM) mosquitoes were first released globally, in the Cayman Islands, by UK-based company Oxitec. Further releases followed in Malaysia, Panama and Brazil. In a public relations whitewash, Oxitec has repeatedly claimed that the experiments successfully wiped out nearly 90% of the Aedes aegypti mosquito population, which is one of the […]

READ

Objection to commercial release of MON87460 X NK603 X MON89034 (triple stacked involving drought tolerant maize trait)

In this objection, ACB raises numerous concerns with the application by Monsanto for the commercial release of the triple stacked event. Drought tolerance is a highly complex genetic trait that cannot be addressed by single gene insertions, as shown by the lack of data backing up the applicant’s claim that this GM variety shows “improvements […]

READ

Liability with clipped wings cannot fly

Representatives of civil society bear in mind the impacts of international regimes at the national and local levels. Will they help or will they harm? Bearing in mind biodiversity and people on the ground CSOs discussed the Co-Chair?s Core Elements Paper in conjunction with the proposals on the table in the Subworking Groups. Read here.

READ

Lesotho – GMO Legislation

Evidently influenced by the UNEP-GEF Biosafety Project, the Biosafety Bill has been drafted principally to implement the Biosafety Protocol verbatim, and in so doing, perpetuates some of the weaknesses and deficiencies of the Biosafety Protocol. For instance, the scope of the Biosafety Bill is predicated on the scope of the Biosafety Protocol where the risks […]

READ

Mozambique – GMO Legislation

The proposed biosafety regulatory regime (hereafter referred to as the “draft biosafety law” or “biosafety law”) of the Republic of Mozambique consists of a draft Decree of Council of Ministers, containing the biosafety regulation and 2 draft technical guidelines for risk evaluation as well as public awareness and participation in biosafety and biotechnology related issues. […]

READ